Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2010
11/03/2010CN201618500U Maleic anhydride waste gas recycling system
11/03/2010CN1837198B Tanshinone IIA derivatives and pharmaceutical application thereof
11/03/2010CN101875654A Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
11/03/2010CN101875647A Method for improving plant antibiotic chalcomoracin content in mulberry leaves
11/03/2010CN101875590A Method for synthesizing acrylamide compound
11/03/2010CN101875008A Catalyst for esterification reaction
11/03/2010CN101342159B Application of bromine phenolic compound in preparing medicament for treating type 2 diabetes or adiposis
11/03/2010CN101279964B Guaiane type sesquiterpenes, preparation and medical use thereof
11/02/2010US7825268 Alkoxylactones, alkoxylactams and alkoxythiolactams for controlling processes based on microbial interaction
11/02/2010US7825260 (R)-2-amino-4-(2-benzo[1,3]dioxol-5-yl-benzoxazol-5-yl)-2-methyl-butan-1-ol; for the treatment or prevention of allo- or xenograft acute or chronic rejection or inflammatory or autoimmune disorders, or as a chemotherapeutic agent, e.g a malignant cell anti-proliferative agent
11/02/2010US7825238 Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
11/02/2010US7825145 Antimicrobial and radioprotective compounds
11/02/2010US7824839 cationic lactone containing perfluorinated sulfonate or sulfonimides with iodonium or sulfonium anions as photoacid generator, a polyhydroxystyrene homo or copolymer and a solvent (propylene glycol/1,2-/, monoalkyl ether, ethyl lactone ); semiconductor, heat exposure, pattern forming; development
11/02/2010CA2485201C Camptothecins with a modified lactone ring
11/02/2010CA2451798C Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
11/02/2010CA2400167C Insecticidal anthranilamides
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010123016A1 Carboxylic acid compound
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010122810A1 Aromatic amine derivative, and organic electroluminescent element comprising same
10/28/2010WO2010122799A1 Aromatic amine derivative and organic electroluminescent element comprising same
10/28/2010WO2010110646A8 Aurones as selective pde inhibitors and their use in neurological conditions and disorders
10/28/2010US20100274030 Cyclic ethers
10/28/2010US20100274027 Organic compounds
10/28/2010US20100274006 Clathrate compound, method for controlling concentration of aqueous agricultural chemical active ingredient solution, and agricultural chemical formulation
10/28/2010US20100273883 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
10/28/2010US20100273835 Novel compounds
10/28/2010US20100273801 Betulin derived compounds useful as antibacterial agents
10/28/2010US20100272656 Flavor Molecules
10/28/2010CA2759690A1 Carboxylic acid compound
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/27/2010EP2243775A1 Synthesis of 1-(2,3-Dihydrobenzofuran-4-YL)ethanone as intermediate in the preparation of ramelteon
10/27/2010CN1984897B Light-emitting device material and light-emitting device
10/27/2010CN101874026A Process for production of furan compound
10/27/2010CN101870768A Polyethylene glycol derivatives of activated lactone compounds
10/27/2010CN101869846A Catalyst of first category bi-quinine or bi-quinidine, synthesis method and application
10/26/2010US7820846 by phosgenation of an aminobenzoylsulfamic acid amide intermediate; prepared from a p-nitrobenzoyl chloride or benzoate and a sulfamic acid amide and reducing the nitrobenzoylsulfamic acid amide; isocyanates are crop protection agents
10/26/2010US7820675 Benzofuran compounds
10/26/2010US7820641 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
10/26/2010CA2598725C Fused aromatic compounds having anti-diabetic activity
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2412164C Amidine derivatives as selective antagonists of nmda receptors
10/21/2010WO2010121226A2 Anticancer agents
10/21/2010WO2010118598A1 Crystal form a of furanodiene, the preparation method and the useful for preparing the antitumor drug thereof
10/21/2010WO2010086878A3 Thyroid receptor modulators
10/21/2010WO2009122445A3 Donor- acceptor fluorene scaffolds : a process and uses thereof
10/21/2010US20100267965 3-Alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one Derivatives as Intermediates in the Synthesis of Renin Inhibitors
10/21/2010US20100267947 Exo-selective synthesis of himbacine analogs
10/21/2010US20100267946 Prodrugs of gaba analogs, compositions and uses thereof
10/21/2010US20100267823 Aurones as selective pde inhibitors and their use in neurological conditions and disorders
10/21/2010US20100267822 Aurones as estrogen receptor modulators and their use in sex hormone dependent diseases
10/21/2010US20100267821 Prophylactic or therapeutic agent for irritable bowel syndrome
10/21/2010US20100267768 Process for making modulators of cystic fibrosis transmembrane conductance regulator
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267704 Autophagy Inducing Compounds and Uses Thereof in Treating Autophagy Associated Diseases
10/21/2010US20100267676 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/21/2010US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof
10/21/2010US20100266717 Chemical and biological agents for the control of molluscs
10/20/2010EP2241560A2 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
10/20/2010EP2241559A2 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
10/20/2010EP2240461A1 Substituted furans and use thereof
10/20/2010EP1899299B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
10/20/2010EP1789377B1 Alternative synthesis of renin inhibitors and intermediates thereof
10/20/2010EP1519930B1 Benzoprostacyclin intermediates and methods for their preparation
10/20/2010EP1317431B1 Polyarylcarboxamides useful as lipid lowering agents
10/20/2010CN101868450A Compounds of 2,3-dihydro-benzofuran
10/20/2010CN101868449A Process for preparing tetrahydrofuran
10/20/2010CN101868441A Terephthalic acid composition and process for the production thereof
10/20/2010CN101863957A Method for synchronously extracting tanshinone IIA and salvianolic acid B from danshen root efficiently
10/20/2010CN101863866A Synthesis method of 3,3-dimethylcyclopropane-1,2-dimethylbenzene anhydride
10/20/2010CN101863865A Polyketides and preparation method and application thereof
10/20/2010CN101863864A Furfuraldehyde production bootstrap system
10/20/2010CN101863863A Refining method for crude furfuryl alcohol
10/20/2010CN101863794A 3'-alkoxy spirocyclische tetramic and tetronic acids
10/20/2010CN101863766A Beta-hydroxyisovalerylshikonin derivative and preparation method thereof
10/20/2010CN101862635A Hydrolysis kettle
10/19/2010US7816673 Di-thieno-benzo-thieno-thiophene derivatives; heat treatment; improved solubility
10/19/2010US7816544 Use of an oxidopyrylium species as an intermediate in a chemical reaction; oxidopyrylium species is generated photochemically from a 3-hydroxychromone derivative followed by 1,3-dipolar cycloaddition of the oxidopyrylium species to a dipolarophile
10/19/2010US7816536 4-substituted and 7-substituted indoles, benzofurans, benzothiophenes, benzimidazoles, benzoxazoles, and benzothiazoles and methods for making same
10/19/2010US7816476 dental adhesive, cement, filling, coating; radical polymerization reactivity comparable with methacrylates and little shrinkage during polymerization; bicyclo[3.1.0]hexane alkly acrylates; tricyclo[3.2.1.0-2,4]octane alkyl acrylates
10/19/2010US7816408 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
10/19/2010US7816397 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
10/19/2010US7816389 Organic compounds
10/19/2010US7816378 3-{[(3-amino-3-benzyltetrahydrofuran-2-yl)oxy]methyl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[(methylsulfonyl)(propyl)amino]benzamide, used for preventing the formation of insoluble amyloid proteins
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010CA2464367C Bicyclic compounds
10/19/2010CA2436526C Heterocyclic sulfonamide inhibitors of beta amyloid production
10/19/2010CA2433417C Novel 1,2-diphenylethene derivatives for treatment of immune diseases
10/19/2010CA2419023C Catalyst for aromatic c-o, c-n, and c-c bond formation
10/14/2010WO2010117986A1 Hydrogenation process for the preparation of tetrahydrofuran and alkylated derivatives thereof
10/14/2010WO2010117040A1 Five-membered heterocyclic compound
10/14/2010WO2010116140A1 New process for preparing hydroxylamines and medicaments
10/14/2010WO2010115952A1 Indane derivatives
10/14/2010WO2010115897A2 Synthesis of 1-(2,3-dihydrobenzofuran-4-yl)ethanone as intermediate in the preparation of ramelteon
10/14/2010WO2010094090A3 Synucleinopathies
10/14/2010US20100261786 Prediction of sleep parameter and response to sleep-inducing compound based on per3 vntr genotype
10/14/2010US20100261772 Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators
10/14/2010US20100261760 EP2 Receptor Agonists
10/14/2010US20100261736 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular disease
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 472